MedPath

The Chemo-Sero-Therapeutic Research Institute

🇯🇵Japan
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.kaketsuken.or.jp

A Study of Anti-HIV Monoclonal Antibody KD-247

Phase 1
Completed
Conditions
HIV Infections
Interventions
Drug: Physiological saline
First Posted Date
2009-06-10
Last Posted Date
2012-11-19
Lead Sponsor
The Chemo-Sero-Therapeutic Research Institute
Target Recruit Count
27
Registration Number
NCT00917813
Locations
🇺🇸

Providence Clinical Research, Burbank, California, United States

🇺🇸

Northstar Medical, Chicago, Illinois, United States

🇺🇸

Albany Medical Center, Albany, New York, United States

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath